Northwestern Medicine investigators led by Derek Walsh, Ph.D., professor of Microbiology-Immunology, have discovered how poxviruses disarm and evade mitochondrial-driven antiviral responses for their replication in host cells, according to findings published in Nature Communications.
New web app for COVID-19 immune antibody helps guide vaccine timing
With SARS-COV-2 infection rates rising again, you may be wondering if you should get a COVID-19 vaccine booster shot. Yale physicians have built a tool to help answer these questions.
Timing is everything: How circadian rhythms influence our brains
Why are we mentally sharper at certain times of day? A study led by Jonathan Lipton MD, Ph.D., at Boston Children’s Hospital spells out the relationship between circadian rhythms—the body’s natural day/night cycles—and the brain connections known as synapses.
Fighting brain tumors with the help of viruses and molecules
By harnessing unusual allies, pioneering cancer treatments could reduce the need for invasive surgery and save lives.
Hip-focused physical therapy reduces chronic low back pain for older adults, finds clinical trial
When the University of Delaware’s Gregory Hicks started his research career two decades ago, he was one of only a few people in the United States studying chronic low back pain in people over 60 years old.
BoZ ON RIGHT TRACK
IT is important that the government is in full control of what foreign exchange is earned to help in planning.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Study finds clinicians could be fooled by biased AI, despite explanations
AI models in health care are a double-edged sword, with models improving diagnostic decisions for some demographics, but worsening decisions for others when the model has absorbed biased medical data.
Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells
Scientists have found an experimental small molecule that induces a form of cell death to kill a variety of cancers while enhancing the power of the immune system and leaving healthy cells totally unscathed.
Discovery of drug candidate to potentially tackle ER-positive breast cancer
An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Cancer Therapeutics Cooperative Research Center, have discovered a pre-clinical drug candidate demonstrating anti-tumor activity in Estrogen Receptor (ER) positive breast cancer models.
Scientists develop marmoset eggs and embryos from xenotransplanted ovary tissues
Marmosets are now used in medical and pharmacological research as a model animal of non-human primates. Recently, genetically modified marmosets are also used in research to elucidate human pathology, higher brain functions, etc. However, generation of genetically modified marmosets requires a large number of eggs, and the method of harvesting eggs from female marmosets raises issues of animal welfare and costs.